Saxonov Serge gifted shares in 10x Genomics on September 1, 2026, leaving him with 1,075,249 shares. For investors, the transaction identifies the CEO’s remaining ownership stake after the transfer, while transaction code G records how the gift was classified in the transaction record.
Key Highlights
- Saxonov Serge is identified as chief executive officer of 10x Genomics.
- The share transfer took place on September 1, 2026.
- Transaction code G classified the transfer as a gift.
Saxonov Serge’s 10x Genomics position now stands at 1,075,249 shares after a gift. Serge is identified as the company’s chief executive officer.
Investor Insights
Serge’s ownership following the transfer was recorded at 1,075,249 shares. The transaction record names 10x Genomics, Inc. as the company whose shares were transferred. The disclosed event therefore records both the nature of the transfer and Serge’s resulting shareholding in 10x Genomics.
FAQs
Q: What happened to Saxonov Serge’s 10x Genomics shares?
A: Saxonov Serge gifted shares of 10x Genomics on September 1, 2026. His recorded ownership after the insider transaction was 1,075,249 shares.
Q: What does the transaction mean for 10x Genomics investors?
A: The transaction identifies the remaining 10x Genomics shares owned by CEO Saxonov Serge after the gift. His post-transaction balance was recorded at 1,075,249 shares.
Q: How was Saxonov Serge’s insider transaction classified?
A: The 10x Genomics share transfer was classified under transaction code G. The source identifies code G in connection with the gift made by Serge.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.